Natural inhibitors targeting osteoclast-mediated bone resorption

Bioorganic & Medicinal Chemistry Letters
2006.0

Abstract

Human cathepsin K, matrix metalloproteinase 9, and alpha(V)beta(3) integrin are the key regulators in osteoclast-mediated bone resorption. In this paper, we found natural inhibitors 1-10 for them by enzyme inhibition assays. Inhibitors 1-7, 8-9, and 10 are novel inhibitors of human cathepsin K, matrix metalloproteinase 9, and alpha(V)beta(3), respectively.

Knowledge Graph

Similar Paper

Natural inhibitors targeting osteoclast-mediated bone resorption
Bioorganic & Medicinal Chemistry Letters 2006.0
Synthesis of Peptide Aldehyde Derivatives as Selective Inhibitors of Human Cathepsin L and Their Inhibitory Effect on Bone Resorption
Journal of Medicinal Chemistry 1998.0
Dual carbonic anhydrase/matrix metalloproteinase inhibitors incorporating bisphosphonic acid moieties targeting bone tumors
Bioorganic & Medicinal Chemistry Letters 2014.0
5-Lipoxygenase inhibitors suppress RANKL-induced osteoclast formation via NFATc1 expression
Bioorganic & Medicinal Chemistry 2015.0
Design and synthesis of dual inhibitors for matrix metalloproteinase and cathepsin
Bioorganic & Medicinal Chemistry Letters 2002.0
Syntheses of (±)-shinflavanone and its structural analogues as potent inhibitors of bone resorption pits formation
Bioorganic & Medicinal Chemistry Letters 1999.0
A Novel Bone Resorption Inhibitor, A-75943 Isolated from Streptomyces sp. SANK 61296.
The Journal of Antibiotics 1998.0
Effects and mechanisms of natural plant active compounds for the treatment of osteoclast-mediated bone destructive diseases
Journal of Drug Targeting 2022.0
WF14865A and B, New Cathepsins B and L Inhibitors Produced by Aphanoascus fulvescens. I. Taxonomy, Production, Purification and Biological Properties.
The Journal of Antibiotics 2000.0
WF14865A and B, New Cathepsins B and L Inhibitors Produced by Aphanoascus fulvescens. I. Taxonomy, Production, Purification and Biological Properties.
The Journal of Antibiotics 2000.0